FDA Inspection 828029 — Vitalant

Vitalant — FEI 3001831403

The FDA completed an inspection of Vitalant on April 17, 2013 in Coeur D Alene, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 17, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Coeur D Alene, ID (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records